Solana Co — Director's Dealing 2019

Dec 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2019-12-07

Reporting Person: LaViscount Joyce N (CFO and COO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-07	Employee Stock Option (Right to Buy)	$12.52	D	20000	Disposed	2020-03-16	Class A Common Stock (20000)	Direct
2019-12-07	Employee Stock Option (Right to Buy)	$12.52	A	20000	Acquired	2025-03-16	Class A Common Stock (20000)	Direct
2019-12-07	Employee Stock Option (Right to Buy)	$3.20	D	150000	Disposed	2020-10-21	Class A Common Stock (150000)	Direct
2019-12-07	Employee Stock Option (Right to Buy)	$3.20	A	150000	Acquired	2025-10-21	Class A Common Stock (150000)	Direct
2019-12-07	Employee Stock Option (Right to Buy)	$5.35	D	120000	Disposed	2020-07-13	Class A Common Stock (120000)	Direct
2019-12-07	Employee Stock Option (Right to Buy)	$5.35	A	120000	Acquired	2026-07-13	Class A Common Stock (120000)	Direct

Footnotes

F1: These two reported transactions involved an amendment of an outstanding option originally granted on March 16, 2015 resulting in the deemed cancellation of the March 16, 2015 option and the grant of a replacement option with the same terms other than the expiration date.

F2: Immediately exercisable.

F3: These two reported transactions involved an amendment of an outstanding option originally granted on October 21, 2015 resulting in the deemed cancellation of the October 21, 2015 option and the grant of a replacement option with the same terms other than the expiration date.

F4: These two reported transactions involved an amendment of an outstanding option originally granted on July 13, 2016 resulting in the deemed cancellation of the July 13, 2016 option and the grant of a replacement option with the same terms other than the expiration date.